Post-Traumatic Stress Disorder Treatment Market Size, Demand, Trends, Opportunities and Future Growth 2032

Post-Traumatic Stress Disorder Treatment Market Size – By Drug Type, By Age Group, By Distribution Channel, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Post-Traumatic Stress Disorder Treatment Market Size – By Drug Type, By Age Group, By Distribution Channel, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Published: Dec 2022 Report ID: HLCA2234 Pages: 1 - 259 Formats*:     
Category : Healthcare
Global Post-Traumatic Stress Disorder Treatment Market Overview

According to SPER Market Research, the Global Post-Traumatic Stress Disorder Treatment Market is estimated to reach USD 27.77 billion by 2032 with a CAGR of 5.14%. 

A psychiatric ailment called post-traumatic stress disorder (PTSD) can develop in people who have experienced a severe shock like a natural disaster, a life-threatening situation, a vehicle accident, sexual abuse, etc. PTSD symptoms can start to manifest three months or even a year later. Most PTSD sufferers exhibit symptoms like intrusive memories, avoidance, unfavourable thinking changes, and altered emotional and physical responses. For instance, PTSD in some people may be brought on by the abrupt death of a loved one. Danger perception is heightened in PTSD patients.The market is primarily driven by a strong late-stage product pipeline and rising R&D for the creation of novel medical regimens. The market is primarily being driven by the increase in post-traumatic stress disorder (PTSD) cases around the world.Lack of knowledge about post-traumatic stress disorder may hinder the expansion of the global market for its treatment. The market for treating post-traumatic stress disorder is severely constrained by the high cost of care.The prevalence of post-traumatic stress disorder (PTSD) is rising globally, there are more clinical studies being conducted to treat PTSD, and there has been an increase in the development of new PTSD treatments and medications, all of which have contributed to the market's expansion.

Impact of COVID-19 on the Global Post-Traumatic Stress Disorder Treatment Market  
The market for treating posttraumatic stress disorder (PTSD) has been dramatically impacted by the extraordinary health problem known as the COVID-19 pandemic. Numerous researches have been done that show COVID-19 increases the risk of PTSD, which has increased demand for PTSD therapy. For instance, a review article titled "COVID-19 and posttraumatic stress disorder: The perfect "storm" for mental health" showed that COVID-19 has a significant effect on mental health and poses a significant risk for the emergence of trauma-related disorders, including PTSD, among those who are most vulnerable, such as children, adolescents, and COVID-19 survivors. Thus, the COVID-19 pandemic has positively impacted market growth.



Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2032
 Base year considered 2021
 Forecast period 2022-2032
 Segments coveredBy Drug Type, By Age Group, By Distribution Channel, By End User
 Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa
 Companies CoveredAllergan PLC, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson, Mylan Pharmaceuticals, Pfizer Inc., Sun Pharmaceuticals Pvt Ltd, Teva Pharmaceuticals Industries Ltd.
Key Audience
  • Hospitals
  • Mental Health Centre
  • Outpatient Clinics
Global Post-Traumatic Stress Disorder Treatment Market Segmentation:
1. By Drug Type: 
  • Anti-anxiety
  • Antidepressants
  • Antipsychotics
  • Beta-blockers
  • Monoamine Oxidase
  • Others
2. By Age Group:
  • Paediatrics
  • Geriatrics
  • Adults
3. By Distribution Channel: 
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
4. By End User:
  • Mental Health Center
  • Hospitals
  • Outpatient Clinics
  • Others
5. By Region:
  • Asia-Pacific
  • Europe
  • Middle East & Africa
  • North America
  • South America
Key Topics Covered in the Report:

  • Size of Global Post-Traumatic Stress Disorder Treatment Market (FY’2019-FY’2032)
  • Overview of Global Post-Traumatic Stress Disorder Treatment Market
  • Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Drug Type (Anti-anxiety, Antidepressants, Antipsychotics, Beta-blockers, Monoamine Oxidase, Others)
  • Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Age Group (Paediatrics, Geriatrics, Adults)
  • Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By End User (Mental Health Centre, Hospitals, Outpatient Clinics, Others)
  • Statistical Snap of Global Post-Traumatic Stress Disorder Treatment Market
  • Growth Analysis of Global Post-Traumatic Stress Disorder Treatment Market
  • Problems and Challenges in Global Post-Traumatic Stress Disorder Treatment Market
  • Competitive Landscape in the Global Post-Traumatic Stress Disorder Treatment Market
  • Impact of COVID-19 and Demonetization on Global Post-Traumatic Stress Disorder Treatment Market
  • Details on Recent Investment in Global Post-Traumatic Stress Disorder Treatment Market
  • Competitive Analysis of Global Post-Traumatic Stress Disorder Treatment Market
  • Major Players in the Global Post-Traumatic Stress Disorder Treatment Market
  • SWOT Analysis of Global Post-Traumatic Stress Disorder Treatment Market
  • Global Post-Traumatic Stress Disorder Treatment Market Future Outlook and Projections (FY’2019-FY’2032)
  • Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges 
4.2. COVID-19 Impacts of the Global Post-Traumatic Stress Disorder Treatment Market 

5. Market variables and outlook
5.1. SWOT analysis 
5.1.1 Strengths 
5.1.2 Weaknesses 
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis 
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape 
5.2.4 Technological landscape 
5.2.5 Environmental landscape 
5.2.6 Legal landscape 
5.3. PORTER’S five forces analysis 
5.3.1 Bargaining power of suppliers 
5.3.2 Bargaining power of Buyers 
5.3.3 Threat of Substitute 
5.3.4 Threat of new entrant 
5.3.5 Competitive rivalry
5.4. Heat map analysis

6. Competitive Landscape 
6.1 Global Post-Traumatic Stress Disorder Treatment Manufacturing Base Distribution, Sales Area, Product Type 
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Post-Traumatic Stress Disorder Treatment Market 

7. Global Post-Traumatic Stress Disorder Treatment Market, By DrugType, 2019-2032 (USD Million)
7.1 Anti-anxiety
7.2 Antidepressants
7.3 Antipsychotics
7.4 Beta-blockers
7.5 Monoamine Oxidase
7.6 Others

8. Global Post-Traumatic Stress Disorder Treatment Market, By Age Group, 2019-2032 (USD Million)
8.1 Paediatrics
8.2 Geriatrics
8.3 Adults

9. Global Post-Traumatic Stress Disorder Treatment Market, By Distribution Channel, 2019-2032 (USD Million)
9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 Online Pharmacies

10.  Global Post-Traumatic Stress Disorder Treatment Market, By End User, 2019-2032 (USD Million)
10.1 Mental Health Center
10.2 Hospitals
10.3 Outpatient Clinics
10.4 Others

11. Global Post-Traumatic Stress Disorder Treatment Market, By Region, 2019-2032 (USD Million)
11.1 Global Post-Traumatic Stress Disorder Treatment Size and Market Share by Region (2019-2025) 
11.2 Global Post-Traumatic Stress Disorder Treatment Size and Market Share by Region (2026-2032)
11.3 Asia-Pacific
11.3.1 Australia
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 South Korea
11.3.6 Rest of Asia-Pacific
11.4 Europe
11.4.1 France
11.4.2 Germany
11.4.3 Italy
11.4.4 Spain
11.4.5 United Kingdom
11.4.6 Rest of Europe
11.5 Middle East & Africa
11.5.1 Kingdom of Saudi Arabia 
11.5.2 United Arab Emirates
11.5.3 Rest of Middle East & Africa
11.6 North America
11.6.1 Canada
11.6.2 Mexico
11.6.3 United States
11.7 South America
11.7.1 Argentina
11.7.2 Brazil
11.7.3 Rest of South America

12. Company Profiles
12.1 Allergan PLC
12.1.1 Company details 
12.1.2 Financial outlook
12.1.3 Product summary 
12.1.4 Recent developments

12.2 Amneal Pharmaceuticals LLC
12.2.1 Company details 
12.2.2 Financial outlook
12.2.3 Product summary 
12.2.4 Recent developments

12.3 Apotex Inc.
12.3.1 Company details 
12.3.2 Financial outlook
12.3.3 Product summary 
12.3.4 Recent developments

12.4 AstraZeneca
12.4.1 Company details 
12.4.2 Financial outlook
12.4.3 Product summary 
12.4.4 Recent developments

12.5 Aurobindo Pharma
12.5.1 Company details 
12.5.2 Financial outlook
12.5.3 Product summary 
12.5.4 Recent developments

12.6 Bausch Health Companies Inc.
12.6.1 Company details 
12.6.2 Financial outlook
12.6.3 Product summary 
12.6.4 Recent developments

12.7 Bristol-Myers Squibb
12.7.1 Company details 
12.7.2 Financial outlook
12.7.3 Product summary 
12.7.4 Recent developments

12.8 Eli Lilly and Company
12.8.1 Company details 
12.8.2 Financial outlook
12.8.3 Product summary 
12.8.4 Recent developments

12.9 GlaxoSmithKline PLC
12.9.1 Company details 
12.9.2 Financial outlook
12.9.3 Product summary 
12.9.4 Recent developments

12.10 Johnson and Johnson
12.10.1 Company details 
12.10.2 Financial outlook
12.10.3 Product summary 
12.10.4 Recent developments

12.11 Mylan Pharmaceuticals
12.11.1 Company details 
12.11.2 Financial outlook
12.11.3 Product summary 
12.11.4 Recent developments

12.12 Pfizer Inc.
12.12.1 Company details 
12.12.2 Financial outlook
12.12.3 Product summary 
12.12.4 Recent developments

12.13 Sun Pharmaceuticals Pvt Ltd
12.13.1 Company details 
12.13.2 Financial outlook
12.13.3 Product summary 
12.13.4 Recent developments

12.14 Teva Pharmaceuticals Industries Ltd.
12.14.1 Company details 
12.14.2 Financial outlook
12.14.3 Product summary 
12.14.4 Recent developments

13. List of Abbreviations

14. Reference Links

15. Conclusion

16. Research Scope

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
The Post-Traumatic Stress Disorder Treatment Market is projected to reach USD 27.77 billion by 2032, growing at a CAGR of 5.14% during the forecast period.
The Post-Traumatic Stress Disorder Treatment Market grew in market size from 2021. The Market is expected to reach USD 27.77 billion by 2032, at a CAGR of 5.14% during the forecast period.
The Post-Traumatic Stress Disorder Treatment Market CAGR of 5.14% during the forecast period.
The Post-Traumatic Stress Disorder Treatment Market size is USD 27.77 billion from 2022 to 2032.
The Post-Traumatic Stress Disorder Treatment Market segment is Covered By Drug Type, By Age Group, By Distribution Channel, By End User.
The North America region is anticipated to have the highest market share in the Post-Traumatic Stress Disorder Treatment Market.
The key players in the market include Companies Covered Allergan PLC, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson, Mylan Pharmaceuticals, Pfizer Inc., Sun Pharmaceuticals Pvt Ltd, Teva Pharmaceuticals Industries Ltd.
The market for treating post-traumatic stress disorder is severely constrained by the high cost of care.The prevalence of post-traumatic stress disorder (PTSD) is rising globally, there are more clinical studies being conducted to treat PTSD, and there has been an increase in the development of new PTSD treatments and medications, all of which have contributed to the market's expansion.
Not able to find what you are looking for? Need customization in the existing report?
Click Here
PLACE AN ORDER
  • 15% off
     
    $ 4250
  • 20% off
             
    $ 5650
  • 25% off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
CALL OR EMAIL US
US:
India:
Email:
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us